Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 19 analysts that cover Apellis Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $31.79, which forecasts a 51.67% increase in the stock price over the next year. The lowest target is $18 and the highest is $52.

Price Target: $31.79 (+51.67%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$18	$31.79	$28	$52
Change	-14.12%	+51.67%	+33.59%	+148.09%

Analyst Ratings

The average analyst rating for Apellis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	3	4	4	5	6	6
Buy	7	7	7	6	5	5
Hold	9	8	9	8	8	8
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	20	20	21	20	20	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $45 → $44	Strong Buy	Maintains	$45 → $44	+109.92%	Feb 25, 2026
Lisa Walter RBC Capital	RBC Capital	Hold Maintains $22 → $21	Hold	Maintains	$22 → $21	+0.19%	Feb 25, 2026
Laura Chico Wedbush	Wedbush	Hold Maintains $20 → $18	Hold	Maintains	$20 → $18	-14.12%	Feb 25, 2026
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $45 → $48	Strong Buy	Maintains	$45 → $48	+129.01%	Feb 25, 2026
Eliana Merle Barclays	Barclays	Hold Initiates $24	Hold	Initiates	$24	+14.50%	Jan 28, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

883.75M

Decreased by -11.96%

from 1.00B

Revenue Next Year

1.04B

Increased by 17.57%

from 883.75M

EPS This Year

-1.15

from 0.17

EPS Next Year

-0.23

from -1.15

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	66.56M	75.42M	396.59M	781.37M	1.00B	883.75M	1.04B
Revenue Growth	-73.44%	13.31%	425.83%	97.02%	28.47%	-11.96%	17.57%
EPS	-8.84	-6.15	-4.45	-1.60	0.17	-1.15	-0.23
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	22	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	1.0B	1.3B
Avg	883.8M	1.0B
Low	768.0M	855.6M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	-0.1%	42.5%
Avg	-12.0%	17.6%
Low	-23.5%	-3.2%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	0.44	2.57
Avg	-1.15	-0.23
Low	-1.84	-1.53

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	157.0%	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.